<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>TreatIBS study critiques</title><description>Plain-language critiques of individual IBS studies: what each one found, how it was run, and what it cannot tell you.</description><link>https://ibs.harlanrappaport.com/</link><language>en-us</language><item><title>CBT by telephone or web for refractory IBS: the ACTIB trial and its 24-month follow-up</title><link>https://ibs.harlanrappaport.com/research/critiques/cbt-for-ibs-actib/</link><guid isPermaLink="true">https://ibs.harlanrappaport.com/research/critiques/cbt-for-ibs-actib/</guid><description>ACTIB randomised 558 UK patients with refractory IBS to telephone CBT, web CBT, or usual care. Both CBT arms cut symptom severity at 12 months; telephone CBT held up at 24 months, web CBT partly faded.</description><pubDate>Tue, 13 Oct 2026 00:00:00 GMT</pubDate><category>cbt</category></item><item><title>Gut-directed hypnotherapy for IBS: the IMAGINE trial and the diet comparison</title><link>https://ibs.harlanrappaport.com/research/critiques/gut-directed-hypnotherapy-trials/</link><guid isPermaLink="true">https://ibs.harlanrappaport.com/research/critiques/gut-directed-hypnotherapy-trials/</guid><description>IMAGINE randomised 354 Dutch IBS patients to individual, group, or educational control. Hypnotherapy roughly doubled adequate relief at 3 and 12 months, and group delivery held its own. A look at the evidence.</description><pubDate>Tue, 13 Oct 2026 00:00:00 GMT</pubDate><category>hypnotherapy</category></item><item><title>Low FODMAP vs traditional IBS dietary advice: the Swedish head-to-head trial</title><link>https://ibs.harlanrappaport.com/research/critiques/low-fodmap-vs-traditional-dietary-advice/</link><guid isPermaLink="true">https://ibs.harlanrappaport.com/research/critiques/low-fodmap-vs-traditional-dietary-advice/</guid><description>Böhn et al. randomised 75 Swedish IBS patients to four weeks of low FODMAP or traditional dietary advice. Both groups improved, with no difference between them. A careful read of what that does and does not show.</description><pubDate>Tue, 13 Oct 2026 00:00:00 GMT</pubDate><category>low-fodmap</category></item><item><title>Peppermint oil for IBS: what the pooled trials show, and what the newest trial did not</title><link>https://ibs.harlanrappaport.com/research/critiques/peppermint-oil-meta-analysis/</link><guid isPermaLink="true">https://ibs.harlanrappaport.com/research/critiques/peppermint-oil-meta-analysis/</guid><description>Alammar et al. pooled 12 randomised trials (835 patients) and found peppermint oil beat placebo for global symptoms and pain. A large 2020 trial then missed its regulatory endpoints. Reconciling the two.</description><pubDate>Tue, 13 Oct 2026 00:00:00 GMT</pubDate><category>peppermint-oil</category></item></channel></rss>